Webinars

Raise the Bar With Real-Time Pharmacovigilance Surveillance

Raise the Bar With Real-Time Pharmacovigilance Surveillance

New regulations and guidance in the EU and US hold marketing authorization holders (MAH) to higher standards for the surveillance of adverse event (AE) and product quality compliant (PQC) data.

Our webinar, hosted by Perficient’s Kari Blaho-Owens, Ph.D., director of pharmacovigilance and safety, covered a demonstration of PV Hawk, a risk management tool that gives you quick access to aggregate data for the meaningful analysis of AE and PQC data — all in real time and across all of your safety surveillance practices and interested parties.

Learn how PV Hawk enables you to:

  • Analyze AE data with drill-down capabilities and graphic representations that are easy to interpret
  • Overlay company data with data from FDA AERS for trends and risk/benefit analysis
  • Compare same-in-class drugs or drugs used for similar indications
  • Analyze the impact of drug-drug and drug-disease interactions

 


New regulations and guidance in the EU and US hold marketing authorization holders (MAH) to higher standards for the surveillance of adverse event (AE) and product quality compliant (PQC) data.

Join Perficient’s Kari Blaho-Owens, Ph.D., director of pharmacovigilance and safety, for a demonstration of PV Hawk, a risk management tool that gives you quick access to aggregate data for the meaningful analysis of AE and PQC data — all in real time and across all of your safety surveillance practices and interested parties.

Learn how PV Hawk enables you to:

- Analyze AE data with drill-down capabilities and graphic representations that are easy to interpret
- Overlay company data with data from FDA AERS for trends and risk/benefit analysis
- Compare same-in-class drugs or drugs used for similar indications
- Analyze the impact of drug-drug and drug-disease interactions
New regulations and guidance in the EU and US hold marketing authorization holders (MAH) to higher standards for the surveillance of adverse event (AE) and product quality compliant (PQC) data.

Join Perficient’s Kari Blaho-Owens, Ph.D., director of pharmacovigilance and safety, for a demonstration of PV Hawk, a risk management tool that gives you quick access to aggregate data for the meaningful analysis of AE and PQC data — all in real time and across all of your safety surveillance practices and interested parties.

Learn how PV Hawk enables you to:

- Analyze AE data with drill-down capabilities and graphic representations that are easy to interpret
- Overlay company data with data from FDA AERS for trends and risk/benefit analysis
- Compare same-in-class drugs or drugs used for similar indications
- Analyze the impact of drug-drug and drug-disease interactions
New regulations and guidance in the EU and US hold marketing authorization holders (MAH) to higher standards for the surveillance of adverse event (AE) and product quality compliant (PQC) data.

Join Perficient’s Kari Blaho-Owens, Ph.D., director of pharmacovigilance and safety, for a demonstration of PV Hawk, a risk management tool that gives you quick access to aggregate data for the meaningful analysis of AE and PQC data — all in real time and across all of your safety surveillance practices and interested parties.

Learn how PV Hawk enables you to:

- Analyze AE data with drill-down capabilities and graphic representations that are easy to interpret
- Overlay company data with data from FDA AERS for trends and risk/benefit analysis
- Compare same-in-class drugs or drugs used for similar indications
- Analyze the impact of drug-drug and drug-disease interactions